Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer
Robert E. Coleman(Weston Park Cancer Centre), Emma R. Woodward(University of Leeds), Janet E. Brown(University of Leeds), David Cameron(University of Leeds), R. Bell, David Dodwell(University of Leeds), Maccon Keane(University Hospital Galway), M. Gil(Institut d'Investigació Biomédica de Bellvitge), Claire Davies(University of Leeds), Roger Burkinshaw(Weston Park Cancer Centre), S. J. Houston(Royal Surrey County Hospital), Robert Grieve(University Hospitals Coventry and Warwickshire NHS Trust), Peter Barrett‐Lee(Velindre Cancer Centre), H. Thorpe(University of Leeds)
Cited by 119
Abstract
Related Papers
No related papers found
Powered by citation graph analysis